Monopar Therapeutics (MNPR) Stock Chart & Stock Price History $29.49 -1.41 (-4.56%) Closing price 03/13/2025 04:00 PM EasternExtended Trading$29.84 +0.35 (+1.17%) As of 03/13/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Monopar Therapeutics Stock Price Performance 5 Day Performance+3.69%1 Month Performance-31.58%3 Month Performance+16.19%6 Month Performance+663.99%Year-To-Date Performance+34.05%1 Year Performance+730.70% Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Remove Ads MNPR Stock Chart for Friday, March, 14, 2025 MNPR Chart by TradingViewRemove Ads Monopar Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/13/2025$30.90$29.49-4.56%$31.90$29.4933,280 shs$179.95 million03/12/2025$29.28$30.90+5.53%$34.11$30.2017,799 shs$188.55 million03/11/2025$27.95$29.28+4.76%$31.29$27.3432,654 shs$178.67 million03/10/2025$28.44$27.95-1.72%$29.87$27.0530,438 shs$170.55 million03/07/2025$30.93$28.44-8.05%$30.86$27.8141,254 shs$173.54 million03/06/2025$30.80$30.93+0.42%$31.69$28.6526,569 shs$188.74 million03/05/2025$31.70$30.80-2.84%$32.29$29.2622,554 shs$187.94 million03/04/2025$30.93$31.70+2.49%$31.83$28.5340,259 shs$193.43 million03/03/2025$35.11$30.93-11.91%$37.25$30.8436,783 shs$188.74 million02/28/2025$30.25$35.11+16.07%$36.04$29.4048,536 shs$214.24 million Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/27/2025$31.29$30.25-3.32%$33.40$30.2259,700 shs$184.59 million02/26/2025$31.11$31.29+0.58%$34.00$30.0136,015 shs$190.93 million02/25/2025$35.99$31.11-13.56%$35.28$31.0959,253 shs$189.83 million02/24/2025$40.25$35.99-10.58%$40.68$35.2647,618 shs$219.54 million02/21/2025$40.31$40.25-0.15%$44.16$38.9845,887 shs$245.53 million02/20/2025$44.39$40.31-9.19%$45.60$38.8057,116 shs$245.89 million02/19/2025$44.12$44.39+0.61%$44.39$40.1835,878 shs$270.78 million02/18/2025$43.10$44.12+2.37%$44.12$41.0228,639 shs$269.13 million02/17/2025$43.10$43.10$43.60$39.7257,519 shs$262.91 million02/14/2025$44.68$43.10-3.54%$43.60$39.7257,519 shs$262.91 million02/13/2025$50.52$44.68-11.56%$50.38$43.9759,080 shs$272.55 million Related Companies Cronos Group Stock Price Chart ArriVent BioPharma Stock Price Chart Avadel Pharmaceuticals Stock Price Chart Bicycle Therapeutics Stock Price Chart Immunome Stock Price Chart Anavex Life Sciences Stock Price Chart AbCellera Biologics Stock Price Chart Bicara Therapeutics Stock Price Chart CureVac Stock Price Chart Organogenesis Stock Price Chart Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNPR) was last updated on 3/14/2025 by MarketBeat.com Staff From Our PartnersNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredBITCOINYou're not going to believe this. There's a bizarre new way to make money from crypto... ...and it's not...Awesomely, LLC | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump's 100-Day Plan Triggers Global RetaliationIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNPR Stock Alerts